United States · Funded startup

Who invested in Inovio Pharmaceuticals

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$108Mraised across 2 rounds since 2014, from 2 sources

$63MRound$45MGrant
Latest round
Grant, $45MSept 2015
Biggest round
$63MRound · Mar 2014
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2015
$63MRound$45MGrant
First round
Round, $63M
Mar 2014
Biggest round
$63M
Round · Mar 2014
Between rounds
19 months
from the last two

The rounds

  1. Sept 2015
    Grant$45M1 new

    From a historical funding record

  2. Mar 2014
    Round$63M

    No investor was named in the report.

    From a historical funding record

The exit

ExitBuyerPriceWhen
AcquiredGenetronics BiomedicalundisclosedJan 2005

From historical deal records. Wrong? Tell us.

Everyone who backed them

DARPAVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Inovio Pharmaceuticals

Who invested in Inovio Pharmaceuticals?

Inovio Pharmaceuticals's investors include DARPA.

How much has Inovio Pharmaceuticals raised?

Inovio Pharmaceuticals has raised $108M across 2 rounds since 2014.

When did Inovio Pharmaceuticals last raise?

Inovio Pharmaceuticals's most recent round was a Grant of $45M in Sept 2015.

What was Inovio Pharmaceuticals's biggest round?

Inovio Pharmaceuticals's largest round on record is $63M (Undisclosed round), in Mar 2014.

Who backed Inovio Pharmaceuticals first?

Inovio Pharmaceuticals's first round on record, in Sept 2015, was backed by DARPA.

What stage is Inovio Pharmaceuticals at?

Inovio Pharmaceuticals's latest named round is a Grant, in Sept 2015.

Where is Inovio Pharmaceuticals based?

Inovio Pharmaceuticals is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.